Pharmacodynamics Emax Calculator
Calculate drug effect using Emax model and Hill equation for dose-response relationships.
Why EC50 Is Not Kd
Kd describes binding; EC50 describes effect. They coincide only when effect is directly proportional to occupancy, which is often not the case.
| Situation | EC50 versus Kd |
|---|---|
| Spare receptors | EC50 « Kd — maximal effect at low occupancy |
| Signal amplification | EC50 below Kd |
| Partial agonist | EC50 may approach Kd |
| No amplification | EC50 ≈ Kd |
Receptor reserve is common. Where a tissue has more receptors than needed for a full response, occupying a small fraction produces maximal effect — so EC50 can sit well below Kd. A drug can therefore be more potent in one tissue than another without any difference in binding affinity.
Potency Versus Efficacy
| Potency | Efficacy | |
|---|---|---|
| Measured by | EC50 | Emax |
| Means | How much drug is needed | How large the maximum effect is |
| Clinically | Determines dose | Determines usefulness |
These are routinely conflated. A drug with lower EC50 is more potent — you need less of it — but a drug with higher Emax produces a bigger maximal effect. Efficacy usually matters more clinically; potency mainly affects the dose printed on the tablet.
Morphine and aspirin illustrate this: morphine is far more potent, but the difference that matters is efficacy against severe pain.
The Hill Coefficient
| n | Behaviour | Interpretation |
|---|---|---|
| n = 1 | Hyperbolic | Simple single-site binding |
| n > 1 | Sigmoid, steep | Positive cooperativity — switch-like |
| n < 1 | Shallow | Negative cooperativity or heterogeneous sites |
A steep Hill slope means a narrow concentration range separates no effect from full effect — clinically important because it narrows the therapeutic window. Haemoglobin's n of about 2.8 is the classic biological example.
Worked Examples
Common Mistakes
EC50 measures effect, not occupancy. With spare receptors it can sit far below Kd, so the two are not interchangeable.
EC50 gives potency and Emax gives efficacy. A more potent drug is not necessarily more useful; efficacy usually matters more clinically.
Cooperative systems give steeper curves. A high Hill slope narrows the concentration range between no effect and full effect.
Receptor density differs between tissues, so the same drug can show different EC50 values with unchanged binding affinity.